TrialJournal of acquired immune deficiency syndromes (1999)2012

Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected Thai women enrolled in a phase I safety trial.

Richard E Haaland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.